10-K/A

REXAHN PHARMACEUTICALS 10-K A 12-31-2008

Company: Opus Genetics, Inc.
Filed: March 24, 2009
Period of Report: December 31, 2008
Accession Number: 0001140361-09-007797

View Document ↗ View on SEC.gov ↗